Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Bacterial Infections and Mycoses

Free Subscription 15.12.2025 1 Am J Public Health 26 Antimicrob Agents Chemother 1 Chest 3 Clin Infect Dis 7 Curr Microbiol 31 Diagn Microbiol Infect Dis 1 Eur J Clin Microbiol Infect Dis 3 J Biol Chem 3 J Clin Microbiol 1 J Immunol 1 J Infect Dis 1 J Med Chem 3 J Med Microbiol 1 JAMA 1 Lancet 1 MMWR Morb Mortal Wkly Rep 1 PLoS Biol 1 PLoS Med 5 PLoS Negl Trop Dis 16 PLoS One 8 PLoS Pathog 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Public Health

1. ABRESCH CJ, Stafford IA, Johnson RM, Olabanji K, et al
   Congenital Syphilis: From Near-Elimination to Crisis.
   Am J Public Health. 2026;116:103-112.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

2. YOUSSEF EG, Gebremariam T, Gu Y, Patterson H, et al
   Efficacy assessments of EL219, a next-generation polyene antifungal, in immunosuppressed mice infected with drug-sensitive and drug-resistant Aspergillus isolates.
   Antimicrob Agents Chemother. 2025 Dec 5:e0140025. doi: 10.1128/aac.01400.
   PubMed         Abstract available
   
   
3. ABDELSATTAR AS, Kikiowo B, Abutaleb NS, Dove AS, et al
   Repurposing epetraborole to combat Neisseria gonorrhoeae and Chlamydia trachomatis infections.
   Antimicrob Agents Chemother. 2025 Dec 5:e0144525. doi: 10.1128/aac.01445.
   PubMed         Abstract available
   
   
4. LAVOIE T, Sierra T, Daffinee K, Pogue JM, et al
   Unlocking potentials: the impact of meropenem, meropenem-vaborbactam, and ceftazidime-avibactam in combating carbapenem-resistant Enterobacter cloacae.
   Antimicrob Agents Chemother. 2025 Nov 19:e0090625. doi: 10.1128/aac.00906.
   PubMed         Abstract available
   
   
5. APPLEBACH E, Amburgey-Crovetti K, Bakotic WL, Adhikari TB, et al
   Prevalence and diversity of antifungal resistance in Fusarium isolates across clinical and agricultural settings in the United States.
   Antimicrob Agents Chemother. 2025;69:e0120825.
   PubMed         Abstract available
   
   
6. BLEICK CR, Van Helden SR, Berti AD, Richa R, et al
   Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.
   Antimicrob Agents Chemother. 2025;69:e0069925.
   PubMed         Abstract available
   
   
7. JUAN C-H, Chou S-H, Chuang C, Lin S-N, et al
   Carbapenems versus non-carbapenems as definitive treatment for hypervirulent Klebsiella pneumoniae bacteremia in Taiwan.
   Antimicrob Agents Chemother. 2025;69:e0084625.
   PubMed         Abstract available
   
   
8. HAHN MM, Anderson MS, Snyder M, Du W, et al
   Pharmacokinetic modeling and efficacy of ceftobiprole medocaril against pneumonic tularemia in cynomolgus macaques.
   Antimicrob Agents Chemother. 2025;69:e0127825.
   PubMed         Abstract available
   
   
9. EDWARDS B, Ripperton R, Tilley A, Chastain DB, et al
   Insights into current coccidioidomycosis therapeutic pathways.
   Antimicrob Agents Chemother. 2025;69:e0146525.
   PubMed         Abstract available
   
   
10. NODARI CS, Bai Q, Cayo R, Streling AP, et al
    ISAba1-mediated bla(ADC) disruption restores third-generation cephalosporin susceptibility in a clinical Acinetobacter baumannii isolate.
    Antimicrob Agents Chemother. 2025;69:e0070725.
    PubMed         Abstract available
    
    
11. CADENAS-JIMENEZ I, Gonzalez-Diaz A, Berbel D, Costa-Primo R, et al
    First report of a DIM-1-producing Pseudomonas aeruginosa in Spain: genomic characterization and resistance determinants.
    Antimicrob Agents Chemother. 2025;69:e0131125.
    PubMed         Abstract available
    
    
12. HESELPOTH RD, Euler CW, Fischetti VA
    Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infections.
    Antimicrob Agents Chemother. 2025;69:e0131225.
    PubMed         Abstract available
    
    
13. RODRIGUEZ-OCHOA JL, Sauco-Carballo C, Perez-Palacios P, Merino-Bohorquez V, et al
    Pharmacokinetic/pharmacodynamic optimization of temocillin treatment against CTX-M-15-producing Klebsiella pneumoniae isolates in a hollow-fiber infection model.
    Antimicrob Agents Chemother. 2025;69:e0094625.
    PubMed         Abstract available
    
    
14. ALVARADO-OROSCO N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, et al
    First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology.
    Antimicrob Agents Chemother. 2025;69:e0116325.
    PubMed         Abstract available
    
    
15. WANGCHINDA W, Wu JY, Abbo LM, Ackley R, et al
    Effectiveness of imipenem-relebactam for multidrug-resistant Pseudomonas aeruginosa in pneumonia and bloodstream infections in the United States (MIRAGE).
    Antimicrob Agents Chemother. 2025;69:e0132525.
    PubMed         Abstract available
    
    
16. HE G, Zeng S, Banki LT, Zhou W, et al
    Clinical emergence of inducible macrolide resistance mediated by acquired erm(41) C28T mutation in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2025 Nov 6:e0115325. doi: 10.1128/aac.01153.
    PubMed         Abstract available
    
    
17. FU Y, Zhang Y, Zhao J, Xie J, et al
    Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions.
    Antimicrob Agents Chemother. 2025;69:e0089125.
    PubMed         Abstract available
    
    
18. SLAIN N, Lucas K, Kunz Coyne AJ
    Comparison between cefepime and carbapenem therapy for deep-seated AmpC-producing Enterobacterales infections: a propensity-weighted retrospective cohort study.
    Antimicrob Agents Chemother. 2025;69:e0092825.
    PubMed         Abstract available
    
    
19. HODBERT E, Lemenand O, Thibaut S, Coeffic T, et al
    Exploring multidrug resistance patterns in community-acquired Escherichia coli urinary tract infections with machine learning.
    Antimicrob Agents Chemother. 2025 Oct 31:e0042225. doi: 10.1128/aac.00422.
    PubMed         Abstract available
    
    
20. VANACHAYANGKUL P, Ruamsap N, Caridha D, Imerbsin R, et al
    Preclinical in vitro and in vivo evaluation of omadacycline against multidrug-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2025;69:e0093225.
    PubMed         Abstract available
    
    
21. PAI MP, Cojutti PG, Gatti M, Rinaldi M, et al
    Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
    Antimicrob Agents Chemother. 2025;69:e0121525.
    PubMed         Abstract available
    
    
22. GONZALEZ-PINTO L, Gomis-Font MA, Perez-Rodriguez G, Blanco-Martin T, et al
    Contribution of mutational resistance mechanisms and acquired beta-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2025;69:e0104825.
    PubMed         Abstract available
    
    
23. UPTON CM, Calderin JM, Diacon AH, Boeree MJ, et al
    Cerebrospinal fluid penetration of cycloserine/terizidone and clofazimine in patients with pulmonary TB.
    Antimicrob Agents Chemother. 2025;69:e0093125.
    PubMed         Abstract available
    
    
24. TAKEI K, Kanamori H, Sakata R, Ogawa M, et al
    High-risk clonal expansion of IMP-producing Enterobacter cloacae complex in regional Japanese healthcare settings.
    Antimicrob Agents Chemother. 2025;69:e0095325.
    PubMed         Abstract available
    
    
25. CUI Y, Feng X, Wang J, Liu L, et al
    Construction and assessment of a predictive framework for Enterobacterales bloodstream infection in real-world adult onco-hematology patients using Lasso-Cox regression.
    Antimicrob Agents Chemother. 2025;69:e0097325.
    PubMed         Abstract available
    
    
26. BENAVENT E, Lora-Tamayo J, Ulldemolins M, Pons-Oltra P, et al
    Efficacy, safety, and population pharmacokinetics of a single 1500mg dose of dalbavancin for short-term therapy in patients with chronic prosthetic joint infections.
    Antimicrob Agents Chemother. 2025;69:e0077325.
    PubMed         Abstract available
    
    
27. SHAW S, Pragasam AK, Chowdhury G, Samanta P, et al
    Genomic portrayal of emerging carbapenem-resistant El Tor variant Vibrio cholerae O1.
    Antimicrob Agents Chemother. 2025 Oct 17:e0074025. doi: 10.1128/aac.00740.
    PubMed         Abstract available
    
    

    
    Chest

28. TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
    Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
    Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

29. MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
    Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
    Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
    PubMed         Abstract available
    
    
30. DALE KD
    Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
    Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
    PubMed         Abstract available
    
    
31. LINDER JA, Watson ME, Wessels MR, Carter DM, et al
    2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal (GAS) Pharyngitis: Risk assessment using clinical scoring systems in children and adults.
    Clin Infect Dis. 2025 Dec 4:ciaf668. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Curr Microbiol

32. WANG Z, Wang T, Qian K, Tang B, et al
    Manganese as a Cofactor in the Immunity of Mycobacterium tuberculosis Infection.
    Curr Microbiol. 2025;83:78.
    PubMed         Abstract available
    
    
33. MEGAT ZAKARIA PN, Lean SS, Mohd Desa MN, Aklilu E, et al
    Genomic Insights into Multidrug-resistant Mammaliicoccus sciuri Carrying Novel Staphylococcal Cassette Chromosome mec (SCCmec) Elements and Plasmids from Farm Ruminants on the East Coast of Peninsular Malaysia.
    Curr Microbiol. 2025;83:72.
    PubMed         Abstract available
    
    
34. WANG L, Wang Y, Yue H, Wang W, et al
    Synergistic Antibacterial Effects of Ceftazidime/Avibactam and Auranofin Combination against Carbapenem-Resistant Klebsiella pneumoniae: In Vitro and in Vivo Evaluation.
    Curr Microbiol. 2025;83:66.
    PubMed         Abstract available
    
    
35. LI P, Wang Y, Xu X
    Ceftazidime Combined with Bifico Improves Therapeutic Efficacy and Intestinal Safety in a Mouse Model of Pseudomonas aeruginosa Pneumonia.
    Curr Microbiol. 2025;83:71.
    PubMed         Abstract available
    
    
36. SINGH I, Sharma J, Sharma D, Ratn A, et al
    Bedaquiline Resistance: A Looming Global Threat in Tuberculosis Management.
    Curr Microbiol. 2025;83:57.
    PubMed         Abstract available
    
    
37. JAMAL U, Rahman ZU, Qadir M, Hamayun M, et al
    Aspergillus Welwitschiae Regulates Response of Wheat at Multiple Levels To Alleviate Induced Chromate Stress.
    Curr Microbiol. 2025;83:60.
    PubMed         Abstract available
    
    
38. SONG D, Qi F, Liu J, Xu T, et al
    In Vitro Antibacterial Effects of Haskap Berry (Lonicera caerulea L.) Ethanol Extract against Diarrheagenic Escherichia coli.
    Curr Microbiol. 2025;83:63.
    PubMed         Abstract available
    
    

    
    Diagn Microbiol Infect Dis

39. BONGOMIN F, Sitenda D, Ssekamatte P, Jonani B, et al
    Method comparison of QIAGEN QuantiFERON-TB gold plus ELISA and LIAISON(R) QuantiFERON-TB gold plus for latent tuberculosis infection detection in pregnant ugandan women.
    Diagn Microbiol Infect Dis. 2025;114:117220.
    PubMed         Abstract available
    
    
40. ELNAGAR RM, Elhosiny MM, Mamoun MA, Anber N, et al
    Serological detection of invasive pulmonary aspergillosis in severely ill COVID-19 patients.
    Diagn Microbiol Infect Dis. 2025;114:117212.
    PubMed         Abstract available
    
    
41. DU M, Zhou J, Zhang Z, Hao T, et al
    Rapid diagnosis of tuberculosis using a three-dimensional nanofiber paper-based electrochemical sensor.
    Diagn Microbiol Infect Dis. 2025;114:117210.
    PubMed         Abstract available
    
    
42. POLLANI C, Floch P, Grouteau G, Brousse A, et al
    Real-life assessment of the VirClia(R) IgG chemiluminescence test for the diagnosis of Bartonella henselae infection.
    Diagn Microbiol Infect Dis. 2026;114:117187.
    PubMed         Abstract available
    
    
43. AZIMIRAD M, Noori M, Looha MA, Anantharajah A, et al
    Effect of sub-minimum inhibitory concentrations of metronidazole, vancomycin, and fidaxomicin on growth rate and virulence of Clostridioides difficile.
    Diagn Microbiol Infect Dis. 2026;114:117184.
    PubMed         Abstract available
    
    
44. YU Z, Jiang Q, Qin J, Zhang Z, et al
    Comparative evaluation of MALDI-TOF MS and PFGE for typing and transmission analysis of Corynebacterium striatum in an ICU setting.
    Diagn Microbiol Infect Dis. 2026;114:117178.
    PubMed         Abstract available
    
    
45. MERTENS K, Thai KTD
    Impact of collection and transport medium on the diagnostic performance of bacterial vaginosis.
    Diagn Microbiol Infect Dis. 2026;114:117182.
    PubMed         Abstract available
    
    
46. MANOJ, Gupta Y, Ghrera AS
    Paper modification strategies for bacterial sensing: Progress and prospects in pathogen detection.
    Diagn Microbiol Infect Dis. 2026;114:117180.
    PubMed         Abstract available
    
    
47. HUANG S, Shi W, Chen L, Liu Y, et al
    Sarocladium strictum meningoencephalitis with cerebral vasculitis: a case report and literature review.
    Diagn Microbiol Infect Dis. 2026;114:117171.
    PubMed         Abstract available
    
    
48. CETINKAYA U, Sezer G, Al Khalif O, Koseoglu E, et al
    Evaluation of the use of vinpocetine in microsporidia infections.
    Diagn Microbiol Infect Dis. 2026;114:117170.
    PubMed         Abstract available
    
    
49. JI H, Zhan S, Yang N, Hou X, et al
    Clinical decision making impact of Next-Generation Sequencing in Pneumocystis jirovecii infection: infection characteristics and prognosis.
    Diagn Microbiol Infect Dis. 2026;114:117175.
    PubMed         Abstract available
    
    
50. LIU M, Chen J, He W, Yu Q, et al
    The first case of subcutaneous Fusariosis in an immunocompetent host in China: A case report.
    Diagn Microbiol Infect Dis. 2026;114:117173.
    PubMed         Abstract available
    
    
51. GASIMOVA M, Gurbanov A, Kadyrova A, Huseynov R, et al
    Diagnostic potential of non-invasive tests for Helicobacter pylori-associated gastroduodenal disease in a resource-limited laboratory setting.
    Diagn Microbiol Infect Dis. 2026;114:117167.
    PubMed         Abstract available
    
    
52. SAMADI N, Hadi N, Hosainzadegan H, Kalani M, et al
    Rapid detection of carbapenem resistance in Klebsiella pneumoniae clinical isolates: Flow cytometry as an alternative to multiplex PCR.
    Diagn Microbiol Infect Dis. 2026;114:117166.
    PubMed         Abstract available
    
    
53. ESMAEILI F, Arjomandzadegan M, Zaboli F, Sarmadian H, et al
    Frequency and antibiotic resistance profile of Clostridioides difficile among cancer patients in an adult hematology-oncology unit: Contributing factors and Follow up.
    Diagn Microbiol Infect Dis. 2026;114:117147.
    PubMed         Abstract available
    
    
54. MARSHALL KA, Chen DJ
    Evaluation of organism inclusion on five rapid blood pathogen identification systems and clinical significance of off-panel organisms.
    Diagn Microbiol Infect Dis. 2026;114:117154.
    PubMed         Abstract available
    
    
55. GHORBEL M, Kolsi F, Makni S, Cherif I, et al
    Exploring complexity: A compelling case of chronic allergic fungal sinusitis caused by Alterna Alternata with intracranial expansion and orbital involvement in an immunocompetent male - An illuminating case study and in-depth literature review.
    Diagn Microbiol Infect Dis. 2026;114:117146.
    PubMed         Abstract available
    
    
56. GUNAYDIN B, Kutlu HH, Kurc MA
    Evaluation of the VITEK 2 second-generation cassette for colistin susceptibility testing in carbapenem-resistant gram-negative bacteria.
    Diagn Microbiol Infect Dis. 2026;114:117148.
    PubMed         Abstract available
    
    
57. SANCHEZ D, de Michelena P, Camacho J, Belizon B, et al
    Rapid detection of susceptibility to the ceftazidime-avibactam/aztreonam combination and cefiderocol in MBL-producing Enterobacterales by MALDI-TOF MS and turbidimetry.
    Diagn Microbiol Infect Dis. 2026;114:117142.
    PubMed         Abstract available
    
    
58. EBINI-AKO TA, Tanih NF, Djakissam W
    Malaria and salmonella typhi co- infection and antibiotic susceptibility in febrile patients at the Buea Regional Hospital.
    Diagn Microbiol Infect Dis. 2026;114:117135.
    PubMed         Abstract available
    
    
59. SCHLABE S, Asseva G, Brands-Jordan U, Hollerbach S, et al
    Surprising uncovering of gram-negative diplococci from blood cultures: First identification of Pseudoroseomonas aerofrigidensis as probable bloodstream infection - clinical and laboratory approach towards an unknown pathogen.
    Diagn Microbiol Infect Dis. 2026;114:117137.
    PubMed         Abstract available
    
    
60. KUCHIBIRO T, Nakamura T, Niki M, Yamasaki K, et al
    In vitro activity of essential antimicrobial agents, including ceftazidime/avibactam, imipenem/relebactam, and cefiderocol, against carbapenem-resistant Gram-negative bacteria primarily harboring the IMP-type carbapenemase gene in the Kinki region of
    Diagn Microbiol Infect Dis. 2026;114:117138.
    PubMed         Abstract available
    
    
61. TRAN A, Amamoto A, Bates M, Leonard J, et al
    Prevalence of Mycoplasma genitalium in a Southern California patient population.
    Diagn Microbiol Infect Dis. 2026;114:117130.
    PubMed         Abstract available
    
    
62. AHMAD J, Khan MA, Atif M, Rahman ZU, et al
    Incidence and antimicrobial resistance profile of multi-drug resistant Salmonella typhi isolated from blood samples in Khyber Pakhtunkhwa, Pakistan.
    Diagn Microbiol Infect Dis. 2026;114:117122.
    PubMed         Abstract available
    
    
63. JIANG B, Koo SH, Ang DSW, Ang TL, et al
    Development of a real-time polymerase chain reaction (RT-PCR) assay for simultaneous detection of Helicobacter pylori infection and genetic mutations associated with clarithromycin resistance: A single-center, cross-sectional study from Singapore.
    Diagn Microbiol Infect Dis. 2026;114:117131.
    PubMed         Abstract available
    
    
64. SOLTAU SR, Monrad NEP, Nielsen AEV, Ehlers-Hansen J, et al
    Pseudomonas guariconensis Necrotizing soft tissue infection, Denmark.
    Diagn Microbiol Infect Dis. 2026;114:117121.
    PubMed         Abstract available
    
    
65. SARTORI L, Sellera FP, Furlan JPR, Moura Q, et al
    Pet-human transmission of CTX-M-8 extended-spectrum beta-lactamase-producing Escherichia coli ST961 and phylogenetic group B2.
    Diagn Microbiol Infect Dis. 2026;114:117120.
    PubMed         Abstract available
    
    
66. HARIDAS H, Raina S, Das P, Kunwar S, et al
    Evaluation of colistin susceptibility among Klebsiella pneumoniae isolates by broth microdilution and colistin agar test.
    Diagn Microbiol Infect Dis. 2026;114:117119.
    PubMed         Abstract available
    
    
67. JIANG F, Zhou X, Zhang H, Yuan H, et al
    Analysis of Predictive Factors for Mycoplasma-associated Plastic Bronchitis in Children.
    Diagn Microbiol Infect Dis. 2026;114:117073.
    PubMed         Abstract available
    
    
68. BAWANKAR NS, Sayed SEH, Bhise SM, Gaind R, et al
    "Is the Ceftazidime-avibactam plus aztreonam combination a solution for infections caused by metallo-beta-lactamase producing carbapenem-resistant Enterobacterales? A call for further investigation".
    Diagn Microbiol Infect Dis. 2026;114:117107.
    PubMed         Abstract available
    
    
69. MASSARO C, Cala C, Anastasia A, Lupo S, et al
    Anaerobic breast abscess caused by Prevotella bivia in non-lactating woman: A case report with diagnostic and clinical implications.
    Diagn Microbiol Infect Dis. 2026;114:117112.
    PubMed         Abstract available
    
    

    
    Eur J Clin Microbiol Infect Dis

70. ZERBATO V, Toc DA, Di Bella S, Lagatolla C, et al
    Synergistic activity of fosfomycin combined with old and new oxazolidinones (linezolid, contezolid, delpazolid, and sutezolid) against bloodstream isolates of vancomycin-resistant Enterococcus faecium.
    Eur J Clin Microbiol Infect Dis. 2025 Dec 12. doi: 10.1007/s10096-025-05372.
    PubMed         Abstract available
    
    

    
    J Biol Chem

71. SIROY A, Sun D, Paul A, Rowland JL, et al
    Oligomerization is Required for Channel Formation of MctB and for Copper Resistance of Mycobacterium tuberculosis.
    J Biol Chem. 2025 Dec 9:111037. doi: 10.1016/j.jbc.2025.111037.
    PubMed         Abstract available
    
    
72. ROSZKOWSKI EK, Charap S, Montague CR, Sukheja P, et al
    Inhibition of de novo fatty acid synthesis in Mycobacterium tuberculosis.
    J Biol Chem. 2025 Dec 8:111022. doi: 10.1016/j.jbc.2025.111022.
    PubMed         Abstract available
    
    
73. SEKI K, Senoo A, Nagatoishi S, Yanaka S, et al
    Structural basis for heme binding by the Shr protein from Streptococcus pyogenes.
    J Biol Chem. 2025 Dec 5:111012. doi: 10.1016/j.jbc.2025.111012.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

74. FENG Z, Ge S, Miao P, Liu M, et al
    Diagnostic performance of the Sanity 2.0 assay to detect resistance to rifampicin, isoniazid, and fluoroquinolones in tuberculosis.
    J Clin Microbiol. 2025 Dec 10:e0129925. doi: 10.1128/jcm.01299.
    PubMed         Abstract available
    
    
75. OLABAMIJI JO, Ochei K, Daniel O, Eneogu R, et al
    Evaluation of stool-based testing to diagnose tuberculosis in children using the Truenat platform in routine settings in Nigeria.
    J Clin Microbiol. 2025 Dec 10:e0104125. doi: 10.1128/jcm.01041.
    PubMed         Abstract available
    
    
76. LI Y, Lin W, Li Z, Tran T, et al
    Whole-genome sequencing-based pathogen characterization for streptococcal infection directly from positive blood culture samples.
    J Clin Microbiol. 2025 Dec 8:e0112625. doi: 10.1128/jcm.01126.
    PubMed         Abstract available
    
    

    
    J Immunol

77. BOTBOL Y, Alves V, Nimrichter L, Macian F, et al
    Extracellular vesicles from Candidozyma (Candida) auris inhibit proliferation of CD4 T cells by disrupting the IL-2 axis.
    J Immunol. 2025 Dec 6:vkaf302. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

78. ERNST JD
    Clinical Commentary on: Targeting Tryptophan Metabolism for Tuberculosis Biomarkers and Host Directed Therapy.
    J Infect Dis. 2025 Dec 11:jiaf624. doi: 10.1093.
    PubMed        
    
    

    
    J Med Chem

79. YE J, Kan CH, Liu J, Tsang TF, et al
    Dithioether Inhibitors of Bacterial RNA Polymerase-Sigma Factor Interactions Exhibit In Vivo Efficacy against MRSA.
    J Med Chem. 2025;68:25352-25374.
    PubMed         Abstract available
    
    

    
    J Med Microbiol

80. NAKANO S, Fujisawa T, Koide S, Sugawara Y, et al
    Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in paediatric patients in Japan (2020-2023).
    J Med Microbiol. 2025;74:002105.
    PubMed         Abstract available
    
    
81. YIN S, Li L, Zhu L, He J, et al
    The synergistic pathogenic mechanism of Brucella melitensis M5-90 effector protein BspC in regulating host cell apoptosis, inflammation and oxidative stress.
    J Med Microbiol. 2025;74:002092.
    PubMed         Abstract available
    
    
82. WU Z, Li X, Dou X, Yang H, et al
    Targeted detection of Helicobacter pylori resistance to clarithromycin and levofloxacin using single-cell Raman spectroscopy.
    J Med Microbiol. 2025;74:002094.
    PubMed         Abstract available
    
    

    
    JAMA

83. BURSTEIN B, Waterfield T, Umana E, Xie J, et al
    Prediction of Bacteremia and Bacterial Meningitis Among Febrile Infants Aged 28 Days or Younger.
    JAMA. 2025 Dec 8:e2521454. doi: 10.1001/jama.2025.21454.
    PubMed         Abstract available
    
    

    
    Lancet

84. LATEEF S
    Aid cuts hampering Nepal's tuberculosis care.
    Lancet. 2025 Dec 4:S0140-6736(25)02469-9. doi: 10.1016/S0140-6736(25)02469.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

85. LIM S, Vagnone PS, Marshall NC, Lees C, et al
    Detection of Paraburkholderia in Clinical Specimens Associated with Use of Nonsterile Ultrasound Gel for Percutaneous Procedures - United States, Canada, and Israel, May 2023?April 2025.
    MMWR Morb Mortal Wkly Rep. 2025;74:615-621.
    PubMed         Abstract available
    
    

    
    PLoS Biol

86. VEZINA B, Cooper HB, Barlow CK, Rethoret-Pasty M, et al
    A metabolic atlas of the Klebsiella pneumoniae species complex reveals lineage-specific metabolism and capacity for intra-species co-operation.
    PLoS Biol. 2025;23:e3003559.
    PubMed         Abstract available
    
    

    
    PLoS Med

87. GOTTLIEB SL, Rees H, Peters RPH
    Vaccines to prevent bacterial sexually transmitted infections: Promise, progress, and public health potential.
    PLoS Med. 2025;22:e1004849.
    PubMed         Abstract available
    
    

    
    PLoS Negl Trop Dis

88. SHRESTHA D, Shrestha B, Ansari S, Sharma S, et al
    Fostering empowerment: Transition from self-help groups to cooperatives in leprosy-affected communities in Nepal.
    PLoS Negl Trop Dis. 2025;19:e0013799.
    PubMed         Abstract available
    
    
89. GASSIEP I, Chewapreecha C, Chantratita N, Oakley T, et al
    Laboratory diagnosis of melioidosis.
    PLoS Negl Trop Dis. 2025;19:e0013761.
    PubMed         Abstract available
    
    
90. ZHAN T, Li Y, Xie Y, Li S, et al
    Multiepitope fusion protein-based ELISA for enhanced brucellosis serodiagnosis.
    PLoS Negl Trop Dis. 2025;19:e0013804.
    PubMed         Abstract available
    
    
91. PROHASKA-BATISTA F, Bridi Cavassin F, de Queiroz-Telles F
    From neglected to notable: A growing public health challenge driven by hospitalization for sporotrichosis in Pernambuco, Northeast Brazil (2016-2024).
    PLoS Negl Trop Dis. 2025;19:e0013795.
    PubMed         Abstract available
    
    
92. KARANI V, Dierro L, Rono A, Githiomi M, et al
    Associated Factors of Mycobacterium Leprae Infection among People with Leprosy in Kwale County.
    PLoS Negl Trop Dis. 2025;19:e0012901.
    PubMed         Abstract available
    
    

    
    PLoS One

93. STANDL F, Senger L, Stich H
    Prevalence of sexually transmitted infections and immunization status among registered sex workers: A pilot study in lower Bavaria, Germany.
    PLoS One. 2025;20:e0338710.
    PubMed         Abstract available
    
    
94. URIBE-RIVERA J, Nava-Ramirez MJ, Escobedo-Aguirre S, Del Rio-Garcia JC, et al
    Generation of a primary culture of chick embryo enterocytes to evaluate the effects of fumonisin B1 and deoxynivalenol on cell morphology, actin filaments and nuclei.
    PLoS One. 2025;20:e0334395.
    PubMed         Abstract available
    
    
95. OCTOBER CD, Baloyi DP, Viljoen L, Raad R, et al
    Using participatory methods to develop a narrative intervention to alleviate distress in children hospitalised with TB in South Africa: The DIMPle project.
    PLoS One. 2025;20:e0338394.
    PubMed         Abstract available
    
    
96. WANG J, Chang T, Wang Y, Zhang J, et al
    Association between Anti-Helicobacter pylori IgG seropositivity on coronary heart disease and potential pathogenesis: a Mendelian randomization study.
    PLoS One. 2025;20:e0329137.
    PubMed         Abstract available
    
    
97. ASMAMAW B, Tadese TT, Mamo RY, Taye BA, et al
    Magnitude of tuberculosis treatment outcomes and associated factors in public health institutions of Arba Minch town, Southern Ethiopia: A multi-centered retrospective cross-sectional study.
    PLoS One. 2025;20:e0338393.
    PubMed         Abstract available
    
    
98. GETAHUN M, Kebede Y, Molalegn H, Alemu A, et al
    Contribution of xpert MTB/RIF assay and Urine LF-LAM for the diagnosis of tuberculosis in children aged 5 - 14 years, at selected health facilities in Ethiopia, 2016 - 2019.
    PLoS One. 2025;20:e0338557.
    PubMed         Abstract available
    
    
99. FOWORA M, Adewale B, Mogaji H, Omolopo I, et al
    Co-infections of Schistosoma mansoni and Helicobacter pylori in school-aged populations and implication for management and control practices in Niger State, Nigeria.
    PLoS One. 2025;20:e0337423.
    PubMed         Abstract available
    
    
100. TEMBO D, Musonda NC, Simwaka M, Nkwemu C, et al
     Rapid progression and short-term mortality during the January 2023 to July 2024 Cholera outbreaks in Zambia: A retrospective facility-based study.
     PLoS One. 2025;20:e0330969.
     PubMed         Abstract available
     
     
101. HERNANDEZ VM, Gama-Martinez Y, Segovia L, Hernandez-Lucas I, et al
     Functional role of 18 LysR-Type transcriptional regulators of Salmonella enterica serovar Typhi.
     PLoS One. 2025;20:e0338130.
     PubMed         Abstract available
     
     
102. MARKUS I, Meurs L, Wood R, Razafimbia V, et al
     Knowledge, attitude and practices among Healthcare Workers towards Pulmonary Plague Infection following an outbreak in Madagascar, 2017: A pilot study.
     PLoS One. 2025;20:e0336589.
     PubMed         Abstract available
     
     
103. GETIE M, Tafere W, Tsega A, Gebreyesus T, et al
     Antimicrobial resistance profiles of bacteria from clinical specimens at Amhara Public Health Institute, Bahir Dar, Ethiopia: A retrospective study.
     PLoS One. 2025;20:e0337332.
     PubMed         Abstract available
     
     
104. VACCA P, Vescio F, D'Ancona F, Fazio C, et al
     Neisseria meningitidis serogroup B causing invasive disease, Italy, 2010-2021.
     PLoS One. 2025;20:e0337446.
     PubMed         Abstract available
     
     
105. MOHAMMED FA, Sarkar R, Ayele F, Urgesa K, et al
     Nasopharyngeal carriage of Streptococcus pneumoniae, its associated factors, and antimicrobial susceptibility patterns among school children in Babile district, eastern Ethiopia.
     PLoS One. 2025;20:e0337950.
     PubMed         Abstract available
     
     
106. KATEETE DP, Namakula S, Kigozi E, Katabazi FA, et al
     Patterns of compensatory mutations in rpoA/B/C genes of multidrug resistant M. tuberculosis in Uganda.
     PLoS One. 2025;20:e0328957.
     PubMed         Abstract available
     
     
107. HUSSEIN AM, Muhialdin AJ, Faraj RK
     Prevalence of antibiotic-resistant Escherichia coli isolates from healthy chicken droppings.
     PLoS One. 2025;20:e0337055.
     PubMed         Abstract available
     
     
108. TIWA BN, Fankam AG, Sonfack CB, Mouozong R, et al
     Correction: Anti-staphylococcal activity, antibiotic-resistance modulation effects and action of Harungana madagascariensis (Hypericaceae) fruit extracts on the antioxidant system of multidrug-resistant Staphylococcus aureus.
     PLoS One. 2025;20:e0338020.
     PubMed         Abstract available
     
     

     
     PLoS Pathog

109. ENZ U, Gul E, Maurer L, Cerepenkaite K, et al
     TTSS-2 virulence drives inflammatory destruction of the gut epithelial barrier and modulates inflammatory response profiles in the Salmonella-infected mouse gut.
     PLoS Pathog. 2025;21:e1013733.
     PubMed         Abstract available
     
     
110. SILVA M, Pinto AJ, Beites T
     Essential redundancies fuel Mycobacterium tuberculosis adaptation to the host.
     PLoS Pathog. 2025;21:e1013749.
     PubMed         Abstract available
     
     
111. MEHRA A, Garrett EM, Serody CJ, Tamayo R, et al
     Phase variation of Clostridioides difficile colony morphology occurs via modulation of cell division.
     PLoS Pathog. 2025;21:e1013471.
     PubMed         Abstract available
     
     
112. BOTHRA A, Pomerantsev A, Schwarz B, Mondal A, et al
     Environmental regulation of toxin production in Bacillus anthracis.
     PLoS Pathog. 2025;21:e1013587.
     PubMed         Abstract available
     
     
113. POSPISILOVA M, Dreus A, Matheova P, Schmidtova J, et al
     Bimodal expression of Type 3 Secretion System 2 enables cooperative virulence among intracellular Salmonella Typhimurium.
     PLoS Pathog. 2025;21:e1013728.
     PubMed         Abstract available
     
     
114. MULLER NF, Wick RR, Judd LM, Williamson DA, et al
     Quantifying plasmid movement in drug-resistant Shigella species using phylodynamic inference.
     PLoS Pathog. 2025;21:e1013621.
     PubMed         Abstract available
     
     
115. BECKMAN I V RL, Martinez B, Santiago FZ, Echeverria GN, et al
     Molecular response to the non-lytic peptide bac7 (1-35) triggers disruption of Klebsiella pneumoniae biofilm.
     PLoS Pathog. 2025;21:e1013437.
     PubMed         Abstract available
     
     
116. ROYER ALM, Dion E, Umansky AA, Avino M, et al
     Structural determinants of SlpA-mediated phage recognition in Clostridioides difficile.
     PLoS Pathog. 2025;21:e1013724.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

117. BANERJEE A, Pickelner S, Smith F, Tenuta LMA, et al
     Fluoride triggers lysis in Streptococcus mutans by inhibition of the Clp protease complex, leading to an unabated competence cascade.
     Proc Natl Acad Sci U S A. 2025;122:e2511884122.
     PubMed         Abstract available
     
     
118. JANET-MAITRE M, Di Venanzio G, Jackson-Litteken CD, Scott NE, et al
     Intracellular Acinetobacter baumannii acts as a transient reservoir in lung infection via a "persist and resist" strategy.
     Proc Natl Acad Sci U S A. 2025;122:e2511369122.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.